Design Therapeutics, Inc. ( DSGN ) is a biotech working on small-molecule medicines for serious genetic conditions. They focus on diseases that are linked to nucleotide repeat expansions. DSGN's platform is Gene Targeted Chimera (GeneTAC), and the company recently had My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a gradu ...